Another subpopulation of Treg (CD4+CD25high cells), that has been proposed having even higher suppressive properties27, was found in significantly lower levels in NSCLC patients compared to the healthy donors (p < 0.0001), regardless the clinical stage or the histology. Here, CD4 is linked to non-small cell lung carcinoma.